进入创新通道！产前胎儿畸形超声影像辅助诊断软件

Core Viewpoint - The article highlights the critical role of early and accurate prenatal ultrasound screening in reducing congenital defects, which are a leading cause of neonatal mortality and disability globally [2][4]. R&D Background - Congenital defects remain a major cause of death and disability among newborns and children, with approximately 240,000 newborns dying within 28 days of birth due to congenital diseases each year [4]. - In China, the burden of diseases caused by congenital defects in children under five has decreased by over 30% in the past five years, although significant regional disparities exist [4]. Product Introduction - Guangzhou Aiyunji focuses on the application of artificial intelligence in prenatal ultrasound since its establishment in 2016, launching the third-generation AI-assisted diagnostic system, Aiyunzhisheng III, based on deep learning and automatic feature extraction [5][6]. Product Features - The system supports real-time analysis of fetal structures and standard planes, achieving 100% accuracy in identifying 13 early pregnancy and 50 mid-to-late pregnancy standard planes [8]. - It can detect 25 types of brain abnormalities and 10 major deformities with sensitivity and specificity exceeding 95% [8]. - The knowledge graph includes information on 115 genetic syndromes, 6 intrauterine infections, and over 200 common deformities [8]. Market Overview - The global AI ultrasound imaging market is projected to grow from approximately $1.05 billion in 2024 to $2.57 billion by 2034, with a CAGR of 8.6% [10]. - The obstetric ultrasound equipment market is expected to increase from $2.13 billion in 2024 to $2.84 billion by 2030 [10]. - The Chinese AI imaging market is estimated to reach approximately 13.74 billion yuan by 2030, driven by high penetration in top-tier hospitals and accelerated promotion in grassroots healthcare [10]. Competitors - International players include Philips, GE HealthCare, and Samsung Medison, each offering AI-enhanced ultrasound solutions [12][14]. - Domestic competitors include Mindray and Lanwang Technology, which have developed various AI functionalities for prenatal ultrasound [15][16]. Company Overview - Guangzhou Aiyunji has established itself as an innovative company in the prenatal ultrasound field, with multiple patents and collaborations with top research institutions [16]. - The Aiyunzhisheng product has been recognized and trialed in numerous top-tier hospitals across 22 provinces in China, receiving regulatory approvals for medical device registration [16].